PMID- 32174986 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240328 IS - 1735-1995 (Print) IS - 1735-7136 (Electronic) IS - 1735-1995 (Linking) VI - 25 DP - 2020 TI - Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? PG - 14 LID - 10.4103/jrms.JRMS_1056_18 [doi] LID - 14 AB - BACKGROUND: Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) has not been suggested by guidelines, since new systemic chemotherapy options have improved overall survival. However, the effect of PTR is still controversial in mCRC. In this study, we aimed to evaluate the effect of PTR on survival in unresectable mCRC. MATERIALS AND METHODS: Two hundred and fifty-two patients with unresectable mCRC were screened retrospectively between January 2007 and December 2017 and a total of 147 patients who met inclusion criteria were included. The patients with emergency or elective PTR and the patients without surgery were compared for baseline features and overall survival. RESULTS: The median follow-up time was 15.6 months (range; 1.2-78.9) in whole patients. There were 91 patients in nonsurgical (NS) group and 56 patients in PTR group. The median overall survival was significantly longer in PTR group compared NS group (21.8 vs. 17.0 months, P = 0.01), but it was not associated to better overall survival in multivariate Cox analysis (hazard ratio: 0.65, 95% confidence interval: 0.41-1.02, P = 0.06). There was no significant difference in overall survival between emergency and elective surgery subgroups (22.9 vs. 16.1 months, respectively, P = 0.9). CONCLUSION: PTR did not offer an overall survival benefit in this study. Although it is debated, we think that it is better to start treatment with chemotherapy and biological agent combinations in patients with asymptomatic mCRC. Thus, the patients can be protected from the morbidity and mortality of the surgery. CI - Copyright: (c) 2020 Journal of Research in Medical Sciences. FAU - Ergun, Yakup AU - Ergun Y AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Bal, Oznur AU - Bal O AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Dogan, Mutlu AU - Dogan M AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Ucar, Gokhan AU - Ucar G AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Dirikoc, Merve AU - Dirikoc M AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Acikgoz, Yusuf AU - Acikgoz Y AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. FAU - Bacaksiz, Ferhat AU - Bacaksiz F AD - Department of Gastroenterology, Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey. FAU - Uncu, Dogan AU - Uncu D AD - Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey. LA - eng PT - Journal Article DEP - 20200220 PL - India TA - J Res Med Sci JT - Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences JID - 101235599 PMC - PMC7053176 OTO - NOTNLM OT - Colectomy OT - colorectal cancer OT - metastatic OT - palliative surgery OT - survival COIS- There are no conflicts of interest. EDAT- 2020/03/17 06:00 MHDA- 2020/03/17 06:01 PMCR- 2020/02/20 CRDT- 2020/03/17 06:00 PHST- 2018/12/31 00:00 [received] PHST- 2019/02/15 00:00 [revised] PHST- 2019/11/22 00:00 [accepted] PHST- 2020/03/17 06:00 [entrez] PHST- 2020/03/17 06:00 [pubmed] PHST- 2020/03/17 06:01 [medline] PHST- 2020/02/20 00:00 [pmc-release] AID - JRMS-25-14 [pii] AID - 10.4103/jrms.JRMS_1056_18 [doi] PST - epublish SO - J Res Med Sci. 2020 Feb 20;25:14. doi: 10.4103/jrms.JRMS_1056_18. eCollection 2020.